Many people regain weight after stopping GLP-1 medicines. Long-term support may be as important as the drugs themselves.
Articles on Weight loss jabs
Displaying all articles
Appetite is governed by gut hormones, not willpower. GLP-1 therapies extend natural satiety signals and expose the biology behind eating.
Semaglutide (better known as Wegovy) may help people with obesity lose up to 25% of their body weight when used at a higher dose.
Up to a third of the weight lost while taking weight loss jabs such as Wegovy and Mounjaro includes muscle and bone mass.
Wegovy might be effective at treating everything from arthritis to alcohol addiction.
Top contributors
-
Postdoctoral Research Fellow, Edge Hill University
-
Professor in Clinical Biochemistry, University of Westminster
-
Lecturer in Physiotherapy, Institute of Population Health, University of Liverpool
-
Senior Lecturer, Life Sciences, University of Westminster
-
Associate Professor of Metabolic Medicine, University of Surrey